Recent medical advancements cover new treatments for chronic kidney disease, improved cancer screening, and public health challenges surrounding infectious disease and inflammation.

The FDA has approved finerenone for adults with type 1 diabetes and chronic kidney disease, marking the first new treatment for this condition in over three decades.

A new deep learning model utilizing 3D mammography has been developed to accurately predict an individual's 5-year risk for developing breast cancer.

Pennsylvania health officials have requested emergency CDC assistance to manage a significant measles outbreak amid ongoing national political debates regarding vaccination policy.

New research indicates that both active and passive smoke exposure are significantly linked to a higher risk of hidradenitis suppurativa in children and adolescents.

A comprehensive meta-analysis has confirmed that patients diagnosed with systemic lupus erythematosus (SLE) face a substantially higher risk of experiencing both ischemic and hemorrhagic strokes.

Medical experts are currently debating the efficacy of upfront dual therapy versus sequential escalation treatments for patients suffering from pulmonary fibrosis.

A new executive order proposing to increase the number of vaccination visits has sparked concern among clinicians who prefer minimizing painful medical encounters for children.

Omalizumab has shown promise in treating antihistamine-resistant chronic spontaneous urticaria by reducing systemic inflammation and specific D-dimer blood markers.